Cardioprotective effects of curcumin against myocardial I/R injury: A systematic review and meta-analysis of preclinical and clinical studies
Frontiers in Pharmacology · 09.03.2023 · 14
DOI: 10.3389/fphar.2023.1111459 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.03.2023. Verfasst von Tianli Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Myocardial ischemia-reperfusion (I/R) injury is a complex clinical problem that often leads to further myocardial injury. Curcumin is the main component of turmeric, which has been proved to have many cardioprotective effects. However, the cardioprotective potential of curcumin remains unclear. The present systematic review and meta-analysis aimed to evaluate the clinical and preclinical (animal model) evidence regarding the effect of curcumin on myocardial I/R injury.
Methods
Eight databases and three register systems were searched from inception to 1 November 2022. Data extraction, study quality assessment, data analyses were carried out strictly. Then a fixed or random-effects model was applied to analyze the outcomes. SYRCLE’s-RoB tool and RoB-2 tool was used to assess the methodological quality of the included studies. RevMan 5.4 software and stata 15.1 software were used for statistical analysis.
Results
24 animal studies, with a total of 503 animals, and four human studies, with a total of 435 patients, were included in this study. The meta-analysis of animal studies demonstrated that compared with the control group, curcumin significantly reduced myocardial infarction size ( p < 0.00001), and improved the cardiac function indexes (LVEF, LVFS, LVEDd, and LVESd) ( p < 0.01). In addition, the indexes of myocardial injury markers, myocardial oxidation, myocardial apoptosis, inflammation, and other mechanism indicators also showed the beneficial effect of curcumin ( p < 0.05). In terms of clinical studies, curcumin reduced the incidence of cardiac dysfunction, myocardial infarction in the hospital and MACE in the short term, which might be related to its anti-inflammatory and anti-oxidative property. Dose-response meta-analysis predicted, 200 mg/kg/d bodyweight was the optimal dose of curcumin in the range of 10–200 mg/kg/d, which was safe and non-toxic according to the existing publications.
Conclusion
Our study is the first meta-analysis that includes both preclinical and clinical researches. We suggested that curcumin might play a cardioprotective role in acute myocardial infarction in animal studies, mainly through anti-oxidative, anti-inflammatory, anti-apoptosis, and anti-fibrosis effects. In addition, from the clinical studies, we found that curcumin might need a longer course of treatment and a larger dose to protect the myocardium, and its efficacy is mainly reflected on reducing the incidence of myocardial infarction and MACE. Our finding provides some meaningful advice for the further research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
- National Integrated Traditional and Western Medicine Center for Cardiovascular Disease, China-Japan Friendship Hospital, Beijing, China.
- Center for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
- Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Beijing, China.
- Department of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zitieren
APA
Li, T., Jin, J., Pu, F., Bai, Y., Chen, Y., Li, Y., & Wang, X. (2023). Cardioprotective effects of curcumin against myocardial I/R injury: A systematic review and meta-analysis of preclinical and clinical studies. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1111459
Vancouver
Li T, Jin J, Pu F, Bai Y, Chen Y, Li Y, et al. Cardioprotective effects of curcumin against myocardial I/R injury: A systematic review and meta-analysis of preclinical and clinical studies. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1111459
BibTeX
@article{Li2023,
author = {Li, Tianli and Jin, Jialin and Pu, Fenglan and Bai, Ying and Chen, Yajun and Li, Yan and Wang, Xian},
title = {Cardioprotective effects of curcumin against myocardial I/R injury: A systematic review and meta-analysis of preclinical and clinical studies},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1111459}
}
EUVIMED